: Formulation & Drug Delivery

Formulation & Drug Delivery

25 - 26 April 2024 | London, UK
10th Annual
Formulation & Drug Delivery Congress25 - 26 April 2024 | London, UK

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development

The Formulation & Drug Delivery Congress includes...

Leading expert scientists working across formulation, drug delivery, bioanalysis, developability, and manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic institutions. 

Over 50 technical presentations and case studies focused on the critical topics in AI for automated formulations, enhanced drug delivery through vaccines, PROTAC, and exosomes, as well as an exploration of sustainable drug development.

Maximise your experience with our fully featured Event App, with selected presentations available to watch on-demand and extensive networking features

PLUS interactive opportunities including:

  • Roundtable discussions
  • Panel discussions
  • Workshops 

Agenda at a Glance

Day One

  • Technologies advancing drug product development
  • Recent advances to improve bioavailability:
       » Permeability
       » Solubility
  • Stability challenges and solutions
  • Characterisation, solid state
  • Sustainable drug product manufacturing processes
  • Fast-track formulation
  • Long-acting injectable forms
  • Digitalisation & automation of processes:
       » AI/ML
       » In silico modelling
  • Innovative delivery for biologics:
       » Advances in delivery device development
  • New modalities delivery: ADCs, nanobodies
  • Receptor targeting systems
  • Overcoming oral delivery challenges
  • Vaccine delivery technologies
  • Lipid nanoparticles to deliver biologics
  • Exosome mediated drug delivery
  • Ocular drug delivery 
  • Characterisation & stability updates
  • Bioanalytical methods improving drug product development
  • Developability assessment
  • Regulatory frameworks
  • Device combination product control strategies
  • Powder characterisation and developability
  • Challenges with excipients and polysorbate stability
  • Protein aggregations and preventions
  • Advanced lyophilisation technologies & methods:
       » Development of a lyo digital twin

Day Two

  •  Oral dosage form improvement
  • Topical & transdermal drug delivery
  • Regulatory expectations
  • Combination products & devices
  • Patient-friendly delivery and dosage forms
    • Controlled release formulations
  • PROTAC drug delivery
    •  Driving sufficient bioavailability
    • Clinical applications
  • Nanotechnology approaches:
    • Achieving better deliverability
    • Targeted delivery of nanoparticles


  • Parenteral formulations
  • Drug optimisation (safety & efficacy)
  • Formulation for advanced therapies
  • Vaccines / peptides / proteins formulation development
  • New formulations for oral delivery of peptides
  • Upscaling formulation with digital tools & tech
  • Fill-finish & continuous processing
  • High-dose subcutaneous formulations
  • Long-acting peptide formulations
  • AI/ML to speed up formulation development